APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.

Colorectal cancer is the second leading cause of death from cancer in the United States. Metastases in the liver, the most common metastatic site for colorectal cancer, are found in one-third of the patients who die of colorectal cancer. Currently, the genes and molecular mechanisms that are functionally critical in modulating colorectal cancer hepatic metastasis remain unclear. Here, we report our studies using functional selection in an orthotopic mouse model of colorectal cancer to identify a set of genes that play an important role in mediating colorectal cancer liver metastasis. These genes included APOBEC3G, CD133, LIPC, and S100P. Clinically, we found these genes to be highly expressed in a cohort of human hepatic metastasis and their primary colorectal tumors, suggesting that it might be possible to use these genes to predict the likelihood of hepatic metastasis. We have further revealed what we believe to be a novel mechanism in which APOBEC3G promotes colorectal cancer hepatic metastasis through inhibition of miR-29-mediated suppression of MMP2. Together, our data elucidate key factors and mechanisms involved in colorectal cancer liver metastasis, which could be potential targets for diagnosis and treatment.

[1]  Masahiro Aoki,et al.  Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. , 2011, Cancer cell.

[2]  T. Utsunomiya,et al.  CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma , 2010, Journal of Gastroenterology.

[3]  T. Yeatman,et al.  Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. , 2010, Gastroenterology.

[4]  Yong-jig Cho,et al.  Antimetastatic role of Smad4 signaling in colorectal cancer. , 2010, Gastroenterology.

[5]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[6]  C. Croce,et al.  Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. , 2009, Blood.

[7]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[8]  J. Massagué,et al.  Molecular basis of metastasis. , 2008, The New England journal of medicine.

[9]  O. Fodstad,et al.  The Stem Cell‐Associated Antigen CD133 (Prominin‐1) Is a Molecular Therapeutic Target for Metastatic Melanoma , 2008, Stem cells.

[10]  R. Weinberg.  Leaving home early: reexamination of the canonical models of tumor progression. , 2008, Cancer cell.

[11]  G. Martinelli,et al.  Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice , 2008, British Journal of Cancer.

[12]  G. Steinberg,et al.  Regulation and function of triacylglycerol lipases in cellular metabolism. , 2008, The Biochemical journal.

[13]  N. Deane,et al.  Smad7 induces hepatic metastasis in colorectal cancer , 2008, British Journal of Cancer.

[14]  Ian A. White,et al.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.

[15]  Mina J Bissell,et al.  Is CD133 a marker of metastatic colon cancer stem cells? , 2008, The Journal of clinical investigation.

[16]  Douglas B. Evans,et al.  Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. , 2007, Cancer cell.

[17]  Shraddha S. Nigavekar,et al.  RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling Pathways , 2007, Diseases of the colon and rectum.

[18]  V. Moyer,et al.  Lymph node evaluation and survival after curative resection of colon cancer: systematic review. , 2007, Journal of the National Cancer Institute.

[19]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[20]  M. Malim,et al.  Antiviral Protein APOBEC3G Localizes to Ribonucleoprotein Complexes Found in P Bodies and Stress Granules , 2006, Journal of Virology.

[21]  C. Croce,et al.  MicroRNA expression and function in cancer. , 2006, Trends in molecular medicine.

[22]  C. Croce,et al.  MicroRNAs and chromosomal abnormalities in cancer cells , 2006, Oncogene.

[23]  Mohammad Saleem,et al.  S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9 , 2006, Proceedings of the National Academy of Sciences.

[24]  C. Lepage,et al.  Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population , 2006, The British journal of surgery.

[25]  C. Lepage,et al.  Epidemiology and Management of Liver Metastases From Colorectal Cancer , 2006, Annals of surgery.

[26]  T. Rana,et al.  Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies , 2006, PLoS pathogens.

[27]  Brian S. Roberts,et al.  The colorectal microRNAome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Winstanley,et al.  Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. , 2006, Cancer research.

[30]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[31]  Jun Qin,et al.  Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .

[32]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[33]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[34]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[35]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[36]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[37]  M. Schotz,et al.  The lipase gene family DOI 10.1194/jlr.R200007-JLR200 , 2002, Journal of Lipid Research.

[38]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[39]  R. Dashwood.  Early detection and prevention of colorectal cancer (review). , 1999, Oncology reports.

[40]  A. Leibovitz,et al.  Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.

[41]  H. Kung,et al.  Targeting S100P Inhibits Colon Cancer Growth and Metastasis by Lentivirus-Mediated RNA Interference and Proteomic Analysis , 2011, Molecular medicine.

[42]  Hui Zhang.  The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs. , 2010, Progress in molecular and subcellular biology.

[43]  R. Rhoads.  miRNA regulation of the translational machinery , 2010 .

[44]  R. Rhoads.  miRNA regulation of the translational machinery. Preface. , 2010, Progress in molecular and subcellular biology.

[45]  W. Birchmeier,et al.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis , 2009, Nature Medicine.

[46]  Jialing Huang,et al.  MicroRNA-mediated Protein Translation Inhibition by Apolipoprotein B mRNA-editing Enzyme Catalytic Polypeptide-like 3 G ( APOBEC 3 G ) and Its Family Members * , 2007 .

[47]  Jun Qin,et al.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.

[48]  F. Izzo,et al.  Surgical treatment of colorectal cancer metastasis , 2004, Cancer and Metastasis Reviews.